E
Emmanuel D Dixon
Researcher at Medical University of Vienna
Publications - 9
Citations - 291
Emmanuel D Dixon is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Internal medicine & Chemistry. The author has an hindex of 2, co-authored 3 publications receiving 73 citations.
Papers
More filters
Journal ArticleDOI
Pathophysiological mechanisms of liver injury in COVID-19.
Alexander D. Nardo,Mathias Schneeweiss-Gleixner,May Bakail,Emmanuel D Dixon,Sigurd Lax,Sigurd Lax,Michael Trauner +6 more
TL;DR: The potential pathophysiological mechanisms for SARS‐CoV‐2 hepatic tropism as well as acute and possibly long‐term liver injury in COVID‐19 are discussed.
Journal ArticleDOI
The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD.
TL;DR: In this paper, a review summarizes the roles of lipases and selected nuclear receptors, including peroxisome proliferator-activated receptor γ (PPARγ) and liver X receptor (LXR), in obesity, diabetes, and NAFLD.
Journal ArticleDOI
Hepatocyte-specific deletion of adipose triglyceride lipase (ATGL/PNPLA2) ameliorates dietary induced steatohepatitis in mice
Claudia D. Fuchs,Richard Radun,Emmanuel D Dixon,Veronika Mlitz,Gerald Timelthaler,Emina Halilbasic,Merima Herac,Johan W. Jonker,Onne A H O Ronda,Matteo Tardelli,Matteo Tardelli,Guenter Haemmerle,Robert Zimmermann,Hubert Scharnagl,Tatjana Stojakovic,Henkjan J. Verkade,Michael Trauner +16 more
TL;DR: In this article, a short hairpin RNA-mediated ATGL knockdown was shown to attenuate hepatic steatohepatitis in mice fed with methionine-choline-deficient (MCD) or high-fat high-carbohydrate (HFHC) diet.
Journal ArticleDOI
Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects
Claudia D. Fuchs,Emmanuel D Dixon,Tim Hendrikx,Veronika Mlitz,Annika Wahlström,Marcus Ståhlman,Hubert Scharnagl,Tatjana Stojakovic,Christoph J. Binder,Hanns-Ulrich Marschall,Michael Trauner +10 more
TL;DR: THBA and their downstream targets may represent a potential treatment strategy for cholestatic liver diseases and changes of the hepatic immune cell profile towards an anti‐inflammatory pattern are shown.
Journal ArticleDOI
Peroxisome proliferator activated receptor gamma regulates patatin-like phospholipase domain-containing protein 3 in adipocytes in vitro and in vivo in a mouse model of non-alcoholic steatohepatitis
Emmanuel D Dixon,Thierry Claudel,Alexander D. Nardo,Veronika Mlitz,Claudia D. Fuchs,Michael Trauner +5 more